Literature DB >> 16390644

Development of gentamicin resistance after gentamicin-PMMA beads for treatment of foot osteomyelitis: report of two cases.

Margaret W N Wong1, Mamie Hui.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16390644     DOI: 10.1177/107110070502601216

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


× No keyword cloud information.
  6 in total

Review 1.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

2.  Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.

Authors:  Yaron S Brin; Jacob Golenser; Boaz Mizrahi; Guy Maoz; Abraham J Domb; Shyamal Peddada; Shmuel Tuvia; Abraham Nyska; Meir Nyska
Journal:  J Control Release       Date:  2008-07-20       Impact factor: 9.776

Review 3.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

4.  The Fate of Antibiotic Impregnated Cement Space in Treatment for Forefoot Osteomyelitis.

Authors:  Inha Woo; Jeongjin Park; Hyungyu Seok; Tae-gon Kim; Jun Sung Moon; Seung Min Chung; Chul Hyun Park
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

5.  Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.

Authors:  Ling Yan; Dian-Ming Jiang; Zhi-Dong Cao; Jun Wu; Xin Wang; Zheng-Long Wang; Ya-Jun Li; Yong-Fen Yi
Journal:  Drug Des Devel Ther       Date:  2015-07-20       Impact factor: 4.162

6.  In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.

Authors:  Mateus Trinconi Cunha; Maria Aparecida Murça; Stanley Nigro; Giselle Burlamaqui Klautau; Mauro José Costa Salles
Journal:  BMC Infect Dis       Date:  2018-04-03       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.